Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries - Buvat, Jacques; Tesfaye, Fisseha; Rothman, Margaret; Rivas, David A.; Giuliano, François (European urology, 2009)
Keywords: Adult; Benzylamines - adverse effects; Benzylamines - therapeutic use; Dapoxetine; Distress; Double-Blind Method; Ejaculation; Humans; Intravaginal ejaculatory latency time; Male; Naphthalenes - adverse effects; Naphthalenes - therapeutic use; Perceived control over ejaculation; Premature ejaculation; Selective serotonin reuptake inhibitor; Serotonin Uptake Inhibitors - adverse effects; Serotonin Uptake Inhibitors - therapeutic use; Sexual Dysfunction, Physiological - drug therapy; Urology; Premature ejaculation; Distress; Intravaginal ejaculatory latency time; Perceived control over ejaculation; Dapoxetine; Selective serotonin reuptake inhibitor